Literature DB >> 6980936

Discrepancy in expression ability of Tac antigen and Ia determinants defined by monoclonal antibodies on activated or cultured cord blood T lymphocytes.

T Yokoi, T Miyawaki, A Yachie, S Ohzeki, N Taniguchi.   

Abstract

T lymphocytes from cord blood and adults stimulated with mitogens and alloantigen were analyzed using monoclonal antibodies that detect Ia and Tac antigens associated with lymphocyte activation. Less than 5% of T cells freshly isolated or cultured without stimuli expressed Ia and Tac antigens assessed by the indirect immunofluorescence method. When both T cells from cord blood and adults were cultured with phytohemagglutinin (PHA), concanavalin A (Con A), pokeweed mitogen (PWM), or allogeneic cells, variable proportions of them expressed Tac antigen. The expression of Tac antigen on stimulated T cells increased in parallel with DNA synthesis, and was significantly correlated with the proliferative response of stimulated T cells. In contrast to Tac antigen, the expression of Ia antigens appeared to show some time lag behind the proliferative response. Although expression of Ia antigens was too weak to assess in PHA- or Con A-stimulated cultures, adult T cells were stimulated by PWM or allogeneic cells to express strongly Ia antigens in culture. However, the percentage of Ia+ cells in cord blood T cells stimulated with PWM or allogeneic cells was markedly lower as compared with that of adults. In addition, cord blood T cells grown in the presence of T cell growth factor showed the same degree of Tac antigen as adult ones did, whereas their expression of Ia antigens was negligible as compared with adult controls. These observations suggested that T cells in cord blood might be deficient by nature in their ability to express Ia antigens on activation. The inability to develop Ia+ T cells seemed to be characteristic of functional immaturity of T cells in early human ontogeny.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980936

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Activation of human CD4+ and CD8+ cells by Sarcocystis gigantea lectin.

Authors:  H J Tietz; T Montag; H D Volk; E Brose; R Gantenberg; F F Weichold; T Hiepe
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies.

Authors:  C B Wilson; J Westall; L Johnston; D B Lewis; S K Dower; A R Alpert
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

Review 3.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus.

Authors:  M Popovic; G Lange-Wantzin; P S Sarin; D Mann; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

5.  Insulin responses and lymphocyte subclasses in children with newly diagnosed insulin-dependent diabetes.

Authors:  T Scheinin; J Mäenpää; S Koskimies; B M Dean; G F Bottazzo; S Kontiainen
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

6.  Comparison of phorbol myristate acetate and phytohaemagglutinin as stimulators of in vitro T lymphocyte colony formation of human peripheral blood lymphocytes. I. Surface markers of colony cells.

Authors:  T Suzawa; S Hyodo; T Kishi; H Kashiwa; T Karakawa; E Kittaka; T Sakano; T Usui
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

7.  Increased cyclosporine sensitivity of T cells from cord blood compared with those from the adult.

Authors:  R M McDouall; A J Suitters; H Smith; M H Yacoub; M L Rose
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

8.  Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease.

Authors:  G Pizzolo; M Chilosi; G Semenzato; F Caligaris-Cappio; L Fiore-Donati; G Perona; G Janossy
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.